2014
DOI: 10.1158/0008-5472.can-13-3440
|View full text |Cite
|
Sign up to set email alerts
|

Loss of Cdk2 and Cyclin A2 Impairs Cell Proliferation and Tumorigenesis

Abstract: Cell cycle inhibition has yet to offer a generally effective approach to cancer treatment, but a full evaluation of different combinations of cell cycle inhibitors has yet to be evaluated. Cyclin A2, a core component of the cell cycle, is often aberrantly expressed in cancer where it may impact cell proliferation. In this study, we investigated the role of cyclin A2 in tumorigenesis using a conditional genetic knockout mouse model. Cyclin A2 deletion in oncogene-transformed MEFs suppressed tumor formation in i… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
70
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 106 publications
(77 citation statements)
references
References 34 publications
7
70
0
Order By: Relevance
“…Our observations of the functional connection between USP7/PHF8 and cyclin A2 agree with recent studies reporting that PHF8 promotes cell cycle transition (9,56). In addition, data from the Human Protein Atlas and the literature indicate that cyclin A2 is overexpressed in dozens of cancers (38,39,57), and inhibition of cyclin A2 complexes was shown to suppress tumorigenesis in vitro and in vivo (39,58). Consistent with our observation that USP7-promoted PHF8 stabilization is linked to upregulation of cyclin A2, we showed that the expression level of cyclin A2 is elevated and positively associated with that of PHF8 and USP7 in clinical breast cancer samples.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Our observations of the functional connection between USP7/PHF8 and cyclin A2 agree with recent studies reporting that PHF8 promotes cell cycle transition (9,56). In addition, data from the Human Protein Atlas and the literature indicate that cyclin A2 is overexpressed in dozens of cancers (38,39,57), and inhibition of cyclin A2 complexes was shown to suppress tumorigenesis in vitro and in vivo (39,58). Consistent with our observation that USP7-promoted PHF8 stabilization is linked to upregulation of cyclin A2, we showed that the expression level of cyclin A2 is elevated and positively associated with that of PHF8 and USP7 in clinical breast cancer samples.…”
Section: Discussionsupporting
confidence: 91%
“…Deregulation of cyclin A2 was associated with erroneous cell proliferation and chromosomal instability (38,39), and aberrant expression of cyclin A2 has been linked to multiple types of malignancies, including breast, liver, and lung cancers (38)(39)(40). In light of our observation that USP7-mediated deubiquitination and stabilization of PHF8 regulate the expression of cyclin A2, it is reasonable to postulate that the USP7/PHF8 signaling pathway plays a role in cell proliferation and carcinogenesis.…”
Section: Resultsmentioning
confidence: 88%
“…In mouse embryos, cyclin B1 is essential to bring cells into mitosis . Cyclin A2, the somatic paralogue of the mammalian cyclin A family, is essential for development, but mouse embryonic fibroblasts can proliferate in the absence of this cyclin . In mammalian cells, cyclin A2 depletion causes defects both in S‐phase progression and in G2 phase .…”
Section: Pulling the Trigger: Cdk1 Activationmentioning
confidence: 99%
“…Mice with loss of Ccna2 exhibit early embryonic lethality (48). In cancer, Ccna2 is often aberrantly expressed and impacts cell proliferation (49). The CDC25 protein phosphatases (CDC25A, -B, and -C) drive cell cycle transitions by activating key components of the cell cycle engine (50).…”
Section: Discussionmentioning
confidence: 99%